Home » Topics » Regulatory » Patents

Patents
RSS

Schering-Plough presents novel gamma-secretase modulators

March 12, 2009

Novel nAChR receptor modulators claimed by NeuroSearch

March 12, 2009

GlaxoSmithKline presents novel IGF-1R inhibitors for cancer treatment

March 12, 2009

NK3 receptor antagonists claimed by Roche

March 12, 2009

Schering-Plough presents novel alpha2C adrenoreceptor agonists

March 11, 2009

Organon claims TRVP1 modulators for treatment of pain

March 11, 2009

Novel non-nucleoside reverse transcriptase inhibitors claimed by GlaxoSmithKline

March 11, 2009

Novel androgen receptor agonists developed by Takeda

March 11, 2009

GlaxoSmithKline claims quinoxaline derivatives as PI3 kinase inhibitors

March 11, 2009

Novel inhibitors of MDM2 and p53 interaction claimed by Janssen Pharmaceutica

March 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...